EML4 and lung carcinoma: For example, an expected EML4-ALK fusion and an unexpected AGK-BRAF fusion was detected in a lung cancer sample harboring a known EML4-ALK fusion at Laboratory A during the TST170 validation and was confirmed by orthogonal testing with a different NGS assay (Boyle et al., 2020).